X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs STERLING BIOTECH - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD STERLING BIOTECH ALEMBIC LTD/
STERLING BIOTECH
 
P/E (TTM) x 76.1 -1.8 - View Chart
P/BV x 2.8 0.1 3,978.9% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ALEMBIC LTD   STERLING BIOTECH
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
STERLING BIOTECH
Dec-13
ALEMBIC LTD/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs5311 502.9%   
Low Rs293 861.8%   
Sales per share (Unadj.) Rs4.726.8 17.6%  
Earnings per share (Unadj.) Rs8.8-15.0 -58.7%  
Cash flow per share (Unadj.) Rs9.0-5.5 -164.8%  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.754.9 50.5%  
Shares outstanding (eoy) m267.03267.87 99.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.70.3 3,354.7%   
Avg P/E ratio x4.7-0.5 -1,006.9%  
P/CF ratio (eoy) x4.6-1.3 -358.4%  
Price / Book Value ratio x1.50.1 1,169.1%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,9621,862 588.8%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m238547 43.5%   
Avg. sales/employee Rs ThNM5,303.3-  
Avg. wages/employee Rs ThNM403.8-  
Avg. net profit/employee Rs ThNM-2,959.0-  
INCOME DATA
Net Sales Rs m1,2607,181 17.6%  
Other income Rs m26443 619.2%   
Total revenues Rs m1,5247,223 21.1%   
Gross profit Rs m83947 8.7%  
Depreciation Rs m612,543 2.4%   
Interest Rs m04,377 0.0%   
Profit before tax Rs m285-5,931 -4.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m6-1,924 -0.3%   
Profit after tax Rs m2,343-4,007 -58.5%  
Gross profit margin %6.613.2 49.8%  
Effective tax rate %2.132.4 6.6%   
Net profit margin %185.9-55.8 -333.2%  
BALANCE SHEET DATA
Current assets Rs m1,68914,335 11.8%   
Current liabilities Rs m48649,809 1.0%   
Net working cap to sales %95.4-494.0 -19.3%  
Current ratio x3.50.3 1,206.9%  
Inventory Days Days217403 53.8%  
Debtors Days Days81171 47.5%  
Net fixed assets Rs m1,62455,432 2.9%   
Share capital Rs m534268 199.4%   
"Free" reserves Rs m5,96013,935 42.8%   
Net worth Rs m7,40414,701 50.4%   
Long term debt Rs m1049,478 1.1%   
Total assets Rs m8,01073,988 10.8%  
Interest coverage x950.7-0.4 -267,822.8%   
Debt to equity ratio x00.6 2.2%  
Sales to assets ratio x0.20.1 162.1%   
Return on assets %29.30.5 5,839.8%  
Return on equity %31.6-27.3 -116.1%  
Return on capital %31.3-6.4 -486.9%  
Exports to sales %2.925.9 11.4%   
Imports to sales %28.90.2 16,985.0%   
Exports (fob) Rs m371,860 2.0%   
Imports (cif) Rs m36412 2,981.1%   
Fx inflow Rs m371,860 2.0%   
Fx outflow Rs m36525 1,466.2%   
Net fx Rs m-3281,835 -17.9%   
CASH FLOW
From Operations Rs m3461,719 20.1%  
From Investments Rs m-48-3,148 1.5%  
From Financial Activity Rs m-3011,426 -21.1%  
Net Cashflow Rs m-3-3 88.2%  

Share Holding

Indian Promoters % 64.0 33.9 188.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.0 -  
FIIs % 9.7 9.9 98.0%  
ADR/GDR % 0.0 16.9 -  
Free float % 26.1 39.3 66.4%  
Shareholders   54,701 21,482 254.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  AJANTA PHARMA  UNICHEM LAB  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 16, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - VENUS REMEDIES COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS